{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:38:58Z","timestamp":1726429138588},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fortschr Neurol Psychiatr"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Autoimmunenzephalitiden bilden eine heterogene Gruppe neurologischer und\n                    psychiatrischer Erkrankungen. Es werden Antik\u00f6rper-vermittelte\n                    Enzephalitiden von den h\u00e4ufig paraneoplastisch auftretenden\n                    Antik\u00f6rper-assoziierten Enzephalitiden unterschieden. W\u00e4hrend\n                    die Antik\u00f6rper im ersten Fall direkt krankheitsverursachend sind, dienen\n                    sie im zweiten Fall als diagnostischer Biomarker mit hoher Aussagekraft\n                    f\u00fcr einen zugrunde liegenden Tumor.<\/jats:p>","DOI":"10.1055\/a-1803-8805","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T23:35:52Z","timestamp":1667864152000},"page":"529-542","source":"Crossref","is-referenced-by-count":1,"title":["Autoimmun vermittelte Enzephalitis"],"prefix":"10.1055","volume":"90","author":[{"given":"Rosa","family":"R\u00f6\u00dfling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Pr\u00fc\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"H. Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"F Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists:\n                    mechanisms and models","volume":"18","author":"J Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-Mediated Encephalitis","volume":"378","author":"J Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"H Pr\u00fcss","year":"2012","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after\n                    herpes simplex encephalitis: a prospective observational study and retrospective\n                    analysis","volume":"17","author":"T Armangu\u00e9","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/nxi.0000000000001014","article-title":"Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes","volume":"8","author":"F Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"F Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase\n                    antibodies: diagnostic clues for this association","volume":"131","author":"A Saiz","year":"2008","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint\n                    inhibitors","volume":"16","author":"F Graus","year":"2019","journal-title":"Nat Reviews Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric\n                    Patients","volume":"8","author":"J Herken","year":"2017","journal-title":"Front Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3390\/jcm9092683","article-title":"Apheresis in Autoimmune Encephalitis and Autoimmune Dementia","volume":"9","author":"R R\u00f6\u00dfling","year":"2020","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"E Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1212\/nxi.0000000000000962","article-title":"Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome","volume":"8","author":"J Werner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A\n                    Systematic Analysis","volume":"10","author":"T Blinder","year":"2019","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor\n                    encephalitis","volume":"79","author":"S E Schmitt","year":"2012","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological\n                    findings and tumour association in 50 patients","volume":"123","author":"S H Gultekin","year":"2000","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor\n                    encephalitis","volume":"88","author":"F Scheibe","year":"2017","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s13063-020-04516-7","article-title":"Generate-Boost: study protocol for a prospective, multicenter, randomized\n                    controlled, double-blinded phase II trial to evaluate efficacy and safety of\n                    bortezomib in patients with severe autoimmune encephalitis","volume":"21","author":"J Wickel","year":"2020","journal-title":"Trials"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/wnl.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"A van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of Cognitive Deficits and Structural Hippocampal Damage in\n                    Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies","volume":"74","author":"C Finke","year":"2017","journal-title":"JAMA Neurol"}],"container-title":["Fortschritte der Neurologie \u00b7 Psychiatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1803-8805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:05:30Z","timestamp":1719515130000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1803-8805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,7]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1803-8805","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-4299","1439-3522"],"issn-type":[{"type":"print","value":"0720-4299"},{"type":"electronic","value":"1439-3522"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}